Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 212 for “"Thromboxane"”.
-
Synthesis of thromboxane A2 analogues.
The aim of the project was to synthesize novel thromboxane A2 analogues which would be potential thromboxane A2 antagonists. Three thromboxane A2 analogues were synthesized, methyl 7-[-5-(3-hydroxy-1-(E)-octenyl)-2-methylbicyclo[3.3.1]non-2-en-9-yl]-[syn]-(+/-)-5-(Z)-heptenoate, methyl …
-
Thromboxane Biosynthesis and its Inhibition in Man
… product of arachidonic acid in the platelet is thromboxane A2 This compound is the most potent endogenous platelet agonist and vasoconstrictor known in man. Thromboxane A has been implicated in diverse human diseases in which platelet activation and vasospasm are known to occur. There has …
-
Development of Methodology for the Measurement of Prostacyclin and Thromboxane Production: Possible Relevance of Prostacyclin/Thromboxane Balance in Clinical Conditions
… of our knowledge of prostaglandins and thromboxane and the synthesis, metabolism and actions of prostacyclin and thromboxane. Chapter 3 then presents work on the development and validation of a radioimmunoassay to measure plasma prostacyclin metabolite levels. Comparisons are made of …
-
MOLECULAR PHYSIOLOGY OF THROMBOXANE A2 GENERATION IN PLATELETS
… 1) a crucial intermediate enzyme involved in thromboxane biosynthesis. Clopidogrel on the other hand antagonizes ADP receptor P2Y12. ADP is a weak platelet agonist stored in platelet dense granules and is released upon platelet activation. ADP activates platelets through two purinergic …
-
The Effect of Anti-Hypertensive Agents on Platelets, Prostacyclin and Thromboxane and Observations on Prostacyclin and Thromboxane in Normal and Hypertensive Pregnancy
… from platelet deposition and subsequent damage. Thromboxane A2(TxA2) is the major product of arachidonic acid metabolism in platelets, and has actions directly opposed to those of prostacyclin as it is a potent vasodilator and platelet aggregating agent, which is synthesised and released when …
-
Role Of Thromboxane Receptor-Alpha In Prostate Cancer Progression
Thromboxane A2 (TXA2) is a major arachidonic acid metabolite that signals through TXA2 receptors (TP) to induce platelet aggregation and smooth muscle contraction. TXA2 receptors are expressed as two different isoforms in humans, namely TP-alpha (TPα) and TP-beta (TPβ), which have common and …
-
Targeting Thromboxane A2 Receptor Signaling in Breast Cancer Metastasis
… with malignant breast cancer. The receptor of thromboxane A2 (TxA2), TP, is a member of the G-protein coupled receptor family. Increased expression of TP at RNA level was found to correlate with a poor prognosis in breast cancer patients; however, it is unknown how TP expression and activities …
-
Synthesis of pinane thromboxane A₂ via suzuki-miyaura coupling
… prostaglandin endoperoxides then further into thromboxane B₂ through the unstable intermediate thromboxane A₂. Pinane thromboxane A₂ is a stable analog of the unstable thromboxane A₂ [2]. Its antithrombotic activity includes the inhibition of platelet aggregation, artery constriction, and …
-
The Role of Thromboxane A2 Receptors in Diabetic Kidney Disease
Thromboxane receptor (TPr) activity is elevated in diabetes and contributes to complications of diabetic kidney disease (DKD). TPr blockade appears to have therapeutic potential. Several rodent models of DKD show attenuation of renal damage and proteinuria upon administration of the TPr antagonist, …
-
Preeclampsia : an imbalance in placental prostacyclin, thromboxane and progesterone production
Thesis (M.S.)--Michigan State University. Department of Physiology, 1985
-
Design, synthesis and pharmacological evaluation of sulfonylureas and sulfonycyanoguanidines as thromboxane A2 receptor antagonists. Insights into selectivity between thromboxane A2 receptor isoforms (TPα et TPβ)
Thromboxane A2 (TXA2) is an important mediator metabolized from arachidonic acid through the cyclooxygenase pathway, mainly in platelets and macrophages. It is a potent inducer of platelet aggregation and smooth muscle contraction. Its overproduction has been detected in pathologies such as stroke, …
-
THROMBOXANE PROSTANOID RECEPTOR: FUNCTION, ACTIVATION AND POSSIBLE TARGET FOR CARDIOVASCULAR PROTECTION
… of death, and one of the main player is TXA2 (Thromboxane A2), a product of arachidonic acid metabolism generated from the activity of thromboxane synthase on prostaglandin H2 intermediate via cyclooxygenase (COX). TXA2 is responsible for platelets activation and aggregation, thrombus …
-
MOLECULAR MECHANISMS OF THROMBOXANE A2 RECEPTOR-MEDIATED INVASION IN LUNG CANCER CELLS
Thromboxane A2 receptor (TP) has been shown to play important roles in multiple aspects of cancer development including regulation of tumor growth, survival and metastasis. Molecular mechanisms of TP mediated cancer cell invasion remain to be identified. TP agonist, I-BOP, significantly elevated …
-
Regulating the Biosynthesis and Signaling of Thromboxane a2 in Hemostasis and Thrombosis
Statement of the problem: TXA2 is a main contributor in hemostasis. TXA2 is mainly produced by the activated platelets, which can activate more platelets, induce platelet aggregation and facilitate the formation of platelet plug. The precursor of TXA2 is AA, which can be metabolized by COX-1 into …
-
Podocytopenia in Diabetic Nephropathy: A Role for the Thromboxane A2 TP Receptor
… of the disease. Significant increases in thromboxane A2 (TXA2) production as well as expression of its receptor in animal models of diabetic nephropathy led to the hypothesis that TXA2 acting via its thromboxane-prostanoid (TP) receptor induces podocytopenia resulting in proteinuria. …
-
Characterization and Targeting of Thromboxane Receptor Dimerization: A Gateway to Novel Therapeutic Developments
Thromboxane A2 (TXA2) contributes to cardiovascular disease (CVD) by activating platelets and vascular smooth muscle cell constriction and proliferation. Despite their preclinical efficacy, pharmacological antagonists of the TXA2 receptor (the TP), a G protein-coupled receptor (GPCR), have not been …
Page 1 of 11